These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12482415)

  • 21. Structural analysis of thrombin complexed with potent inhibitors incorporating a phenyl group as a peptide mimetic and aminopyridines as guanidine substitutes.
    Bone R; Lu T; Illig CR; Soll RM; Spurlino JC
    J Med Chem; 1998 Jun; 41(12):2068-75. PubMed ID: 9622548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-covalent thrombin inhibitors featuring P3-heterocycles with P1-bicyclic arginine surrogates.
    Cui JJ; Araldi GL; Reiner JE; Reddy KM; Kemp SJ; Ho JZ; Siev DV; Mamedova L; Gibson TS; Gaudette JA; Minami NK; Anderson SM; Bradbury AE; Nolan TG; Semple JE
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2925-30. PubMed ID: 12270176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the chiral space within the active site of alpha-thrombin with a constrained mimic of D-Phe-Pro-Arg--design, synthesis, inhibitory activity, and X-ray structure of an enzyme-inhibitor complex.
    Hanessian S; Balaux E; Musil D; Olsson LL; Nilsson I
    Bioorg Med Chem Lett; 2000 Feb; 10(3):243-7. PubMed ID: 10698445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
    Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W
    J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and X-ray crystal structures of human thrombin with synthetic cyanopeptide-analogues.
    Radau G; Fokkens J
    Pharmazie; 2007 Feb; 62(2):83-8. PubMed ID: 17341023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
    Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
    Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues.
    Martin PD; Malkowski MG; DiMaio J; Konishi Y; Ni F; Edwards BF
    Biochemistry; 1996 Oct; 35(40):13030-9. PubMed ID: 8855938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
    Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
    Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.
    Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D
    J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bound structures of novel P3-P1' beta-strand mimetic inhibitors of thrombin.
    St Charles R; Matthews JH; Zhang E; Tulinsky A
    J Med Chem; 1999 Apr; 42(8):1376-83. PubMed ID: 10212123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing the selectivity profile - from substrate analog inhibitors of thrombin and factor Xa to potent matriptase inhibitors.
    Maiwald A; Hammami M; Wagner S; Heine A; Klebe G; Steinmetzer T
    J Enzyme Inhib Med Chem; 2016; 31(sup1):89-97. PubMed ID: 27168215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel thrombin inhibitors incorporating non-basic partially saturated heterobicyclic P1-arginine mimetics.
    Peterlin-Masic L; Mlinsek G; Solmajer T; Trampus-Bakija A; Stegnar M; Kikelj D
    Bioorg Med Chem Lett; 2003 Mar; 13(5):789-94. PubMed ID: 12617892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design and selection of bivalent peptide ligands of thrombin incorporating P4-P1 tetrapeptide sequences: from good substrates to potent inhibitors.
    Su Z; Vinogradova A; Koutychenko A; Tolkatchev D; Ni F
    Protein Eng Des Sel; 2004 Aug; 17(8):647-57. PubMed ID: 15358856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors.
    Katz BA; Elrod K; Verner E; Mackman RL; Luong C; Shrader WD; Sendzik M; Spencer JR; Sprengeler PA; Kolesnikov A; Tai VW; Hui HC; Breitenbucher JG; Allen D; Janc JW
    J Mol Biol; 2003 May; 329(1):93-120. PubMed ID: 12742021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin inhibitors with novel P1 binding pocket functionality: free energy of binding analysis.
    Mlinsek G; Oblak M; Hodoscek M; Solmajer T
    J Mol Model; 2007 Jan; 13(1):247-54. PubMed ID: 17013633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors.
    Parlow JJ; Kurumbail RG; Stegeman RA; Stevens AM; Stallings WC; South MS
    J Med Chem; 2003 Oct; 46(22):4696-701. PubMed ID: 14561089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety.
    Lange UE; Baucke D; Hornberger W; Mack H; Seitz W; Höffken HW
    Bioorg Med Chem Lett; 2003 Jun; 13(12):2029-33. PubMed ID: 12781189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
    Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
    J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective boron-containing thrombin inhibitors--X-ray analysis reveals surprising binding mode.
    von Matt A; Ehrhardt C; Burkhard P; Metternich R; Walkinshaw M; Tapparelli C
    Bioorg Med Chem; 2000 Sep; 8(9):2291-303. PubMed ID: 11026541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting thrombin and factor VIIa: design, synthesis, and inhibitory activity of functionally relevant indolizidinones.
    Hanessian S; Therrien E; Granberg K; Nilsson I
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2907-11. PubMed ID: 12270173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.